昊帆生物
(301393)
| 流通市值：24.84亿 | | | 总市值：61.02亿 |
| 流通股本：4396.77万 | | | 总股本：1.08亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 202,448,661.97 | 550,441,169 | 534,555,682.4 | 408,664,617 |
| 交易性金融资产 | 831,078,224.7 | 706,878,777.55 | 829,872,558.38 | 902,018,402.66 |
| 应收票据及应收账款 | 257,270,999.49 | 228,044,056.63 | 179,821,143.8 | 183,646,280.5 |
| 其中：应收票据 | 13,399,892.88 | 10,646,076.16 | 9,265,703.74 | 25,277,696.67 |
| 应收账款 | 243,871,106.61 | 217,397,980.47 | 170,555,440.06 | 158,368,583.83 |
| 应收款项融资 | 7,524,592.14 | 4,133,114.21 | 2,562,803.01 | 5,614,581 |
| 预付款项 | 26,998,406.3 | 12,512,265.71 | 12,271,487.29 | 4,261,923.98 |
| 其他应收款合计 | 1,618,487.81 | 2,029,879.09 | 1,235,813.47 | 1,191,077.91 |
| 存货 | 188,160,243.26 | 165,689,961.56 | 165,838,117.44 | 161,183,690.92 |
| 其他流动资产 | 56,196,667.51 | 47,069,509.23 | 33,567,700.93 | 23,418,377.31 |
| 流动资产合计 | 1,571,296,283.18 | 1,716,798,732.98 | 1,759,725,306.72 | 1,689,998,951.28 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 124,531,787.67 | 123,881,486.3 | 123,238,253.42 | 122,602,089.04 |
| 固定资产 | 413,365,542.23 | 393,400,126.86 | 402,395,195.99 | 411,891,818.5 |
| 在建工程 | 484,743,556.42 | 437,706,541.87 | 315,998,466.99 | 217,389,234.8 |
| 使用权资产 | 897,940.77 | 1,246,807.86 | 1,695,180.2 | 2,143,552.52 |
| 无形资产 | 105,280,118.08 | 106,324,081.18 | 106,706,719.42 | 105,425,107.3 |
| 商誉 | 57,853,593.52 | 57,853,593.52 | 57,853,593.52 | 57,853,593.52 |
| 长期待摊费用 | 1,129,071.61 | 76,025.59 | 322,898.8 | 350,671 |
| 递延所得税资产 | 12,229,612.66 | 12,720,888.97 | 11,515,857.93 | 11,990,139.62 |
| 其他非流动资产 | 29,001,657.83 | 29,570,502 | 32,952,515 | 34,764,703.91 |
| 非流动资产合计 | 1,229,032,880.79 | 1,162,780,054.15 | 1,052,678,681.27 | 964,410,910.21 |
| 资产总计 | 2,800,329,163.97 | 2,879,578,787.13 | 2,812,403,987.99 | 2,654,409,861.49 |
| 流动负债: | | | | |
| 短期借款 | - | 10,010,027.78 | 10,011,030.56 | 10,011,030.56 |
| 应付票据及应付账款 | 154,403,770.59 | 278,259,054.78 | 265,070,393.04 | 152,305,833.57 |
| 其中：应付票据 | 27,155,758 | 149,171,035.8 | 172,932,264.8 | 40,984,687 |
| 应付账款 | 127,248,012.59 | 129,088,018.98 | 92,138,128.24 | 111,321,146.57 |
| 合同负债 | 3,274,219.6 | 3,719,764.32 | 1,900,020.58 | 782,474.03 |
| 应付职工薪酬 | 17,515,598.09 | 13,364,842.34 | 10,313,932.35 | 19,617,571.57 |
| 应交税费 | 10,388,636.38 | 10,924,133.27 | 7,206,354.02 | 8,362,907.96 |
| 其他应付款合计 | 22,299,816.65 | 22,352,531.66 | 22,598,845.35 | 23,650,514.94 |
| 一年内到期的非流动负债 | 1,194,010.87 | 1,243,160.39 | 1,167,050.5 | 1,409,434.46 |
| 其他流动负债 | 11,983,804.69 | 10,073,902.45 | 7,003,447.46 | 22,729,166.19 |
| 流动负债合计 | 221,059,856.87 | 349,947,416.99 | 325,271,073.86 | 238,868,933.28 |
| 非流动负债: | | | | |
| 长期借款 | 118,024,957 | 108,420,153 | 76,175,119.6 | 39,467,052.4 |
| 租赁负债 | - | - | 448,085.11 | 444,353.25 |
| 递延收益 | 8,184,514.14 | 8,529,713.58 | 8,874,913.02 | 9,220,112.46 |
| 递延所得税负债 | 6,878,073.63 | 7,114,732.32 | 7,104,470.84 | 7,235,816.82 |
| 非流动负债合计 | 133,087,544.77 | 124,064,598.9 | 92,602,588.57 | 56,367,334.93 |
| 负债合计 | 354,147,401.64 | 474,012,015.89 | 417,873,662.43 | 295,236,268.21 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 108,000,000 | 108,000,000 | 108,000,000 | 108,000,000 |
| 资本公积 | 1,696,820,613.15 | 1,694,308,116.33 | 1,691,767,889.57 | 1,689,936,118.66 |
| 减:库存股 | 33,421,938.39 | 33,421,938.39 | 33,421,938.39 | 33,421,938.39 |
| 其他综合收益 | 145,213.22 | 155,975.98 | 183,087.06 | 106,026.85 |
| 专项储备 | 7,212,290 | 6,273,018.3 | 5,524,814.45 | 4,840,115.17 |
| 盈余公积 | 54,000,000 | 54,000,000 | 54,000,000 | 54,000,000 |
| 未分配利润 | 608,383,296.7 | 571,194,416.53 | 562,831,937.64 | 529,387,239.08 |
| 归属于母公司股东权益合计 | 2,441,139,474.68 | 2,400,509,588.75 | 2,388,885,790.33 | 2,352,847,561.37 |
| 少数股东权益 | 5,042,287.65 | 5,057,182.49 | 5,644,535.23 | 6,326,031.91 |
| 股东权益合计 | 2,446,181,762.33 | 2,405,566,771.24 | 2,394,530,325.56 | 2,359,173,593.28 |
| 负债和股东权益合计 | 2,800,329,163.97 | 2,879,578,787.13 | 2,812,403,987.99 | 2,654,409,861.49 |
| 公告日期 | 2026-10-24 | 2026-08-25 | 2026-04-24 | 2026-04-17 |
| 审计意见(境内) | | | | 标准无保留意见 |